GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Fixed Capital/Sales History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Fixed Capital/Sales(x) | 0.39 | 0.26 |
What is the latest Fixed Capital/Sales ratio of GUFIC BIOSCIENCES ?
| Year | Fixed Capital/Sales |
|---|---|
| Mar2025 | 0.39 |
| Mar2024 | 0.26 |
How is Fixed Capital/Sales of GUFIC BIOSCIENCES Trending?
| Years | Fixed Capital/Sales | % Change | |
|---|---|---|---|
| Mar2025 | 0.39 | 50.00 | |
| Mar2024 | 0.26 | - | |
Other Financial Ratios of GUFIC BIOSCIENCES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Fixed Capital/Sales ratio of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹2,912.7 Cr | 7.1% | -6.3% | -18.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | 7.1% |
-6.3% |
-18.7% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses